fashion -WSS

fashion

author：leisure time 2025-09-28 01:35:12 - browse：24351

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： 4 dead, 2 in stable condition in Philadelphia shooting: Police

hotspot

explore

WSS

Even great ERs can’t make up for American health disparities

EU climate chief is concerned over the expansion of the coal industry in China

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Commercial surrogacy can be ethical, despite pope’s claims

A timeline of the missing Titanic tourist submersible

hotspot

fashion

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

How one medical school became remarkably diverse

A $475,000 price tag for a new cancer drug: crazy or meh?

Apple is now the first public company to be valued at $3 trillion

FDA drug safety: Singulair case shows systemic surveillance flaws

Tori Bowie and the unacceptable rates of Black maternal death

Vertex non

Jerome Adams on the need for new antivirals for Covid

The real point of Kenneth Smith’s execution by nitrogen gas

hotspot

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

4 dead, 2 in stable condition in Philadelphia shooting: Police

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Leon Gautier, last member of French D

NASA releases new images of 'fingerprint

General Catalyst, Summa Health deal will turn on physician buy

hotspot

hotspot

explore

leisure time